These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 10026041

  • 41. Sending pharma better signals.
    Avorn J.
    Science; 2005 Jul 29; 309(5735):669. PubMed ID: 16051753
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. The ODAC Chronicles: Part 3. The FDA's philosophy and process for cancer drug evaluation and approval.
    Grillo-López AJ.
    Expert Rev Anticancer Ther; 2005 Feb 29; 5(1):1-5. PubMed ID: 15757431
    [No Abstract] [Full Text] [Related]

  • 44. Herbal remedies, nephropathies, and renal disease.
    Myhre MJ.
    Nephrol Nurs J; 2000 Oct 29; 27(5):473-8; quiz 479-80. PubMed ID: 16649322
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Herbal products: what's in the bottle? ...and does it really work?
    Child Health Alert; 2002 Nov 29; 20():1-2. PubMed ID: 12521002
    [No Abstract] [Full Text] [Related]

  • 47. The new age of herbals: a pharmacognosy renaissance.
    Tyler VE.
    J Am Pharm Assoc (Wash); 1999 Nov 29; 39(1):11-2. PubMed ID: 9990179
    [No Abstract] [Full Text] [Related]

  • 48. Crackdown on unproven cancer treatments focuses on internet marketers.
    Ross K.
    J Natl Cancer Inst; 2008 Sep 03; 100(17):1200-2. PubMed ID: 18728276
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. The application of the patent laws to the drug approval process.
    Coggio BD, Cerrito FD.
    Food Drug Law J; 1997 Sep 03; 52(4):345-55. PubMed ID: 10346669
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Alternative treatments for attention-deficit/hyperactivity disorder: does evidence support their use?
    Brue AW, Oakland TD.
    Altern Ther Health Med; 2002 Sep 03; 8(1):68-70, 72-4. PubMed ID: 11795624
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. You say Zantac, I say Xanax: a critique of drug trademark approval and proposals for reform.
    Gentin DA.
    Food Drug Law J; 2000 Sep 03; 55(2):255-67. PubMed ID: 12269368
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Translational medicine and the National Institutes of Health road map: steep grades and tortuous curves.
    Humes HD.
    J Lab Clin Med; 2005 Aug 03; 146(2):51-4. PubMed ID: 16099234
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.